Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tipepidine in Children With ADHD
NCT02305134Phase 2Completed
- Sponsor
- Chiba University
- Start
- Jun 2015
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tipepidine hibenzate in attention deficit hyperactivity disorder (ADHD), sponsored by Chiba University. Started Jun 2015; status: completed.
02
Drugs
tipepidine hibenzate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02305134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02305134.